NanoViricides, Inc.
NNVC
$1.13
-$0.01-0.88%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -5.38% | -3.66% | 31.30% | 63.83% | 58.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.88% | -14.83% | 12.63% | 0.68% | -1.82% |
| Operating Income | 11.88% | 14.83% | -12.63% | -0.68% | 1.82% |
| Income Before Tax | 11.17% | 14.04% | -14.14% | -2.30% | -0.09% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.17% | 14.04% | -14.14% | -2.30% | -0.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.17% | 14.04% | -14.14% | -2.30% | -0.09% |
| EBIT | 11.88% | 14.83% | -12.63% | -0.68% | 1.82% |
| EBITDA | 11.17% | 15.16% | -14.06% | -0.56% | 2.16% |
| EPS Basic | 32.47% | 32.53% | 9.04% | 14.00% | 10.42% |
| Normalized Basic EPS | 32.46% | 32.49% | 8.99% | 13.96% | 10.40% |
| EPS Diluted | 32.47% | 32.53% | 9.04% | 14.00% | 10.42% |
| Normalized Diluted EPS | 32.46% | 32.49% | 8.99% | 13.96% | 10.40% |
| Average Basic Shares Outstanding | 32.18% | 29.06% | 27.40% | 20.56% | 11.85% |
| Average Diluted Shares Outstanding | 32.18% | 29.06% | 27.40% | 20.56% | 11.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |